Clinical Trial

A Clinical Trial of SIBP-A16 Injection in Healthy Adults

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo/positive control Phase Ia clinical trial evaluating the safety, tolerability, and pharmacokinetics of SIBP-A16 injection in healthy adults
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-30.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07106918
Lead Sponsor Shanghai Institute Of Biological Products
Conditions Respiratory Syncytial Virus (RSV)
Enrollment 140 participants
Start Date 2025-08-17
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-25